首页> 外文期刊>International Journal of Applied and Basic Medical Research >Bedaquiline: First FDA-approved tuberculosis drug in 40 years

【24h】

Bedaquiline: First FDA-approved tuberculosis drug in 40 years

机译：Bedaquiline：40年来首个获得FDA批准的结核病药物

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Applied and Basic Medical Research》 |2013年第1期|共2页
作者
Rajiv Mahajan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities [J] . Mingote Laia Ruiz, Namutamba Dorothy, Apina Francis, The Lancet . 2015,第9966期

机译：苯达喹啉在治疗耐药性和药物敏感性结核病的方案中的使用：受结核病影响社区的观点
2. A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis [J] . The European respiratory journal : . 2020,第1期

机译：含有耐药结核病患者的含贝壳丝丝和Delamanid的方案
3. A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis [J] . Olatunde Olayanju, Aliasgar Esmail, Jason Limberis, The European respiratory journal : . 2020,第1期

机译：含有耐药结核病患者的含贝壳丝丝和Delamanid的方案
4. The sustained-release effect of triple anti-tuberculosis drugs carried by calcium sulfate/poly-amino acid compound materials in bone tuberculosis lesion [C] . Na Wang, Yongyan Zou, Kang Yang International Conference on Advanced Materials and Technology for Sustainable Life . 2019

机译：硫酸钙/聚氨基酸复合材料在骨结核病病变中携带三重抗结核药物的缓释作用
5. Drug Resistance in Mycobacterium tuberculosis: An Investigation of Drug Transporter P-Glycoprotein and an Evaluation of Improved Diagnosis of Drug Resistant Tuberculosis in Cameroonian Pulmonary Tuberculosis Patients [D] . Abanda, Ngu Njei 2017

机译：结核分枝杆菌的耐药性：转运蛋白P-糖蛋白的调查和喀麦隆肺结核患者耐药性结核病改善诊断的评估
6. In Vitro Drug Susceptibility of Bedaquiline Delamanid Linezolid Clofazimine Moxifloxacin and Gatifloxacin against Extensively Drug-Resistant Tuberculosis in Beijing China [O] . Yu Pang, Zhaojing Zong, Fengmin Huo, 2017

机译：贝达喹啉地拉曼尼利奈唑胺氯法齐明莫西沙星和加替沙星在体外广泛耐药结核病的体外药物敏感性
7. Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase [O] . Marco Fiorillo, Cristian Scatena, Antonio Giuseppe Naccarato, 2021

机译：通过靶向ATP合酶（ATP5F1C）的ATP合酶的γ亚基（ATP5F1C），Bedaquiline抑制了体内的线粒体ATP生产和转移。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号